The purpose of this study is to compare the efficacy of etanercept and sulphasalazine in the treatment of Ankylosing Spondylitis.
Official Title
A Randomized, Double-Blind Study Evaluating the Safety and Efficacy of Etanercept and Sulphasalazine in Subjects With Ankylosing Spondylitis
Conditions
Ankylosing Spondylitis
Study Type
Interventional
Study Design
Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Further Details
Primary Outcome Measures:
- To compare the efficacy of etanercept with sulphasalazine in the treatment of ankylosing spondylitis.
Secondary Outcome Measures:
- To compare the effect of etanercept with sulphasalazine on the quality of life. To evaluate the safety of etanercept.
Study Start
December 2005
Eligibility & Criteria
- Ages Eligible for Study: 18 Years and above
- Genders Eligible for Study: Both
Inclusion Criteria:
- Clinical diagnosis of ankylosing spondylitis
- Active ankylosing spondylitis
Exclusion Criteria:
- Complete ankylosis of spine
- Previous treatment with etanercept
Total Enrolment
525
Contact Details
- Heidelberg West, Victoria, 3081, Australia; Recruiting
- Shenton Park, Western Australia, 6000, Australia; Recruiting
Email Trial managers:
- clintrialparticipation@wyeth.com
- medinfo@wyeth.com
Please refer to this study by ClinicalTrials.gov identifier: NCT00247962
All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.